SEC Contract Filing

Filing Date: 2024-10-03

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10_1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ALZAMEND NEURO, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(par value $0.0001 per share)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">At-The-Market Issuance Sales Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">October 3, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4in 0pt 0; text-align: justify">Ascendiant Capital Markets, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 292.5pt 0pt 0; text-align: justify">110 Front Street, Suite 300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 292.5pt 0pt 0; text-align: justify">Jupiter, FL 33477</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5in 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Alzamend Neuro, Inc., a Delaware
corporation (the <U>Company</U>&rdquo;), confirms its agreement (this &ldquo;<U>Agreement</U>&rdquo;) with Ascendiant Capital Markets,
LLC (the &ldquo;<U>Agent</U>&rdquo;), as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance
and Sale of Shares</U>. The Company agrees to issue and sell through or to the Agent, shares (the &ldquo;<U>Placement Shares</U>&rdquo;)
of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), from time to time during the
term of this Agreement and on the terms set forth in this Agreement; <I>provided however</I>, that in no event will the Company issue
or sell through or to the Agent such dollar amount of Placement Shares that&nbsp;would exceed $6.5 million in the aggregate, subject to
General Instruction I.B.6 of Form S-3 (the &ldquo;<U>Maximum Amount</U>&rdquo;). Notwithstanding anything to the contrary contained herein,
the parties hereto agree that compliance with the limitations set forth in this Section 1 on the amount of Placement Shares issued and
sold under this Agreement will be the sole responsibility of the Company and that the Agent will have no obligation in connection with
such compliance provided the Agent follows the trading instructions provided by the Company pursuant to any Placement Notice in all material
respects. The issuance and sale of Placement Shares through or to the Agent will be effected pursuant to the Registration Statement (as
defined below) filed by the Company and declared effective by the U.S. Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;),
though nothing in this Agreement will be construed as requiring the Company to use the Registration Statement to issue Common Stock. Certain
capitalized terms used in this Agreement have the meanings ascribed to them in Section 25.</P>

<P STYLE="font: 10pt Times New Roman; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has filed with
the SEC, in accordance with the provisions of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), and the
rules and regulations thereunder (the &ldquo;<U>Securities Act Regulations</U>&rdquo;), a registration statement on Form S-3 (File No.
333-273610), including a base prospectus, relating to certain securities, including the Placement Shares, to be issued from time to time
by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions
of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;), and the rules and regulations thereunder.
The Company has prepared or will prepare a prospectus supplement specifically relating to the Placement Shares (the &ldquo;<U>Prospectus
Supplement</U>&rdquo;) to the base prospectus included as part of the registration statement. The Company will furnish to the Agent, for
use by it, copies of the prospectus included as part of the registration statement, as supplemented by the Prospectus Supplement. Except
when the context otherwise requires, such registration statement, including all documents filed as part thereof or incorporated by reference
therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the SEC pursuant to Rule&nbsp;424(b)
under the Securities Act Regulations or deemed to be a part of the registration statement pursuant to Rule&nbsp;430B of the Securities
Act Regulations, is herein called the &ldquo;<U>Registration Statement</U>.&rdquo; The base prospectus, including all documents incorporated
therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in